Category: Wall Street BeatSyndicate content

Inogen affirms 2014 outlook, predicts 2015 growth of up to 25%

December 15, 2014 by Val Kennedy

Inogen confirms its outlook for the rest of 2014 and issues its 2015 forecast, predicting revenue growth of 20% to 25% next year.

Inogen affirms 2014 view, predicts 2015 revenue growth of up to 25%

Year in review: 2014 was the year of the medtech IPO

December 10, 2014 by MassDevice staff

The number of initial public offerings for medical device companies jumped fourfold in 2014, according to a MassDevice.com analysis.

Year in review: 2014 was the year of the medtech IPO

Click to enlarge

It was, as predicted, the year of the IPO for medical device companies, with 25 filing initial public offerings during 2014, according to a MassDevice.com analysis.

Symmetry Medical closes surgical spinout, OEM sale

December 8, 2014 by Mark Hollmer

Symmetry Surgical is now officially independent of Symmetry Medical, as the surgical instrument company debuts on the NASDAQ exchange.

Symmetry Medical closes surgical spinout, OEM sale

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Speculation mounts about possible Stryker offer for Smith & Nephew | Medtech Wall Street news for the week of December 1, 2014

December 4, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Will Stryker bid on Smith & Nephew this week?; Medtronic expects to free up to $4B after IRS beef is settled; Second Sight CEO Greenberg: Next-gen 'bionic eye' could treat nearly all forms of blindness; HCA hospitals halt use of uterine fibroid surgical tool

Will Stryker bid on Smith & Nephew this week?

November 24, 2014 by Brad Perriello

HCA hospitals halt use of uterine fibroid surgical tool

November 25, 2014 by MassDevice

HCA Holdings halts the use of laparoscopic power morcellators in uterine fibroid surgeries in all 278 of its facilities, after the FDA raises the warning level on the cancer risk associated with the devices.

HCA hospitals halt use of uterine fibroid surgical tool

(Reuters) — HCA Holdings (NYSE:HCA), the largest for-profit U.S. hospital operator, said a procedure for removing uterine fibroids that's been linked to the spread of cancer will no longer be performed at its facilities.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic expects to free up to $4B after IRS beef is settled

November 25, 2014 by Brad Perriello

Medtronic says it expects to repatriate as much as $4 billion in cash after it resolves a dispute with the IRS involving its Puerto Rico subsidiary.

Medtronic expects to free up to $4B after IRS beef is settled

Medtronic (NYSE:MDT) said today that it expects to land a substantial windfall once it resolves a dispute with the IRS over the next "couple of years."

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Will Stryker bid on Smith & Nephew this week?

November 24, 2014 by Brad Perriello

Speculation mounts again about a possible Stryker offer for Smith & Nephew now that a 6-month no-bid period has ended.

Will Stryker bid on Smith & Nephew this week?

UPDATED Nov. 24 with analysis from Morgan Stanley.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp